Latest Blogs

Feb 19, 2020
Let’s look critically at the prospective trial evaluating the association of ringing a bell with distress experienced by patients with cancer.
Feb 04, 2020
World Cancer Day 2020 is about every one of us, and about asking for our commitment to do something to prevent cancer and support people and communities deal with cancer.
Jan 30, 2020
We can’t do a great job caring for our patients if we are spreading ourselves too thin, writes Dr. Sayeh Lavasani.
Jan 28, 2020
Dr. Inas Abuali confronts that pesky inner voice that occasionally whispers, "You don't really belong here." 
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO. Prior to this role, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Feb 10, 2020
As we begin our work in 2020, I am excited that we are building on the remarkable successes of 2019, and the years before, with growing collaboration and sharpening focus. 
Feb 04, 2020
As we celebrate the 20th anniversary of World Cancer Day this February 4, it’s important to recognize that we are making progress in addressing cancer.
Jan 16, 2020
As the world’s leading organization of oncology professionals who care for people with cancer, ASCO believes it is critical to understand what the public, including patients, think of, expect, and need from the nation’s cancer care system.
Oct 16, 2019
Participants in ASCO's Advocacy Summit discuss the importance of being engaged with health policy to improve the lives of people affected by cancer.
Oct 04, 2019
About 42 million Medicaid patients do not have the guaranteed ability to participate in clinical trials.
May 20, 2019
Dr. Ward and I discuss the policies that public and private insurers use to control the use of anticancer drug therapies, such as prior authorization requirements, restrictive formularies, step therapy, or fail first requirements, and specialty specific tiers.

Pages